Sarah E. Fenton

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)

Sarah V. Holt, Armelle Logié, Barry R. Davies et al. · Cancer Research · 2012 · 83 citations

Dual Mtorc1, Mtor Kinase Inhibitors, Medicine +12

Clinical characterization of colitis arising from anti-PD-1 based therapy

Daniel Wang, Meghan J. Mooradian, Dae Won Kim et al. · OncoImmunology · 2018 · 64 citations · Full text

A multicenter characterization of hepatitis associated with immune checkpoint inhibitors

James R. Patrinely, Ben McGuigan, Sunandana Chandra et al. · OncoImmunology · 2021 · 58 citations · Full text

Multicenter Characterization, Hepatology, Viral Hepatitis +13

Loss of Protein Kinase C δ Gene Expression in Human Squamous Cell Carcinomas

Vipin Yadav, Nicole C. Yanez, Sarah E. Fenton et al. · American Journal Of Pathology · 2010 · 25 citations · Full text

Cancer Research, Cell Regulation, Medicine +8